HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard S Finn Selected Research

Drug Tapering

12/2020Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies.
12/2019Palbociclib with Letrozole in Postmenopausal Women with ER+/HER2- Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA-2 Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard S Finn Research Topics

Disease

79Hepatocellular Carcinoma (Hepatoma)
06/2022 - 02/2009
57Neoplasms (Cancer)
06/2022 - 12/2004
46Breast Neoplasms (Breast Cancer)
01/2022 - 01/2003
10Hypertension (High Blood Pressure)
01/2022 - 04/2011
9Neutropenia
01/2021 - 01/2015
8Fatigue
01/2021 - 04/2011
8Liver Neoplasms (Liver Cancer)
12/2020 - 01/2012
7Disease Progression
01/2022 - 09/2009
5Liver Diseases (Liver Disease)
11/2021 - 01/2018
5Cholangiocarcinoma
10/2019 - 04/2011
4Triple Negative Breast Neoplasms
08/2015 - 11/2007
4Diarrhea
03/2015 - 12/2008
3Inflammation (Inflammations)
01/2022 - 01/2019
3Circulating Neoplastic Cells
01/2022 - 10/2020
3Febrile Neutropenia
01/2021 - 11/2016
3Infections
01/2021 - 07/2004
3Fibrosis (Cirrhosis)
01/2021 - 01/2019
3Leukopenia
01/2019 - 03/2015
3Exanthema (Rash)
02/2017 - 12/2008
3Carcinogenesis
02/2016 - 02/2013
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2013 - 07/2010
2Pain (Aches)
01/2021 - 01/2020
2Back Pain (Backache)
01/2020 - 01/2015
2Proteinuria
10/2019 - 01/2019
2Thrombocytopenia (Thrombopenia)
01/2019 - 12/2013
2Hyponatremia
11/2014 - 10/2013
2Stomach Neoplasms (Stomach Cancer)
04/2013 - 03/2010
2Retinoblastoma (Glioblastoma, Retinal)
03/2011 - 01/2009
1Hepatitis
01/2022
1Ascites
06/2021

Drug/Important Bio-Agent (IBA)

28Sorafenib (BAY 43-9006)FDA Link
04/2022 - 12/2010
24ErbB Receptors (EGF Receptor)IBA
01/2022 - 12/2008
23palbociclibIBA
01/2021 - 01/2009
15Biomarkers (Surrogate Marker)IBA
06/2022 - 12/2013
14Hormones (Hormone)IBA
01/2022 - 05/2013
12Estrogen ReceptorsIBA
10/2020 - 01/2009
11Letrozole (Femara)FDA LinkGeneric
01/2021 - 01/2015
11Trastuzumab (Herceptin)FDA Link
02/2015 - 01/2003
10RamucirumabIBA
01/2022 - 12/2013
10Phosphotransferases (Kinase)IBA
02/2019 - 11/2007
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 02/2009
9Proteins (Proteins, Gene)FDA Link
10/2019 - 12/2008
8Bevacizumab (Avastin)FDA Link
04/2022 - 02/2009
8pembrolizumabIBA
04/2022 - 01/2018
8alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022 - 10/2014
8Lapatinib (GW572016)FDA Link
02/2014 - 12/2008
7lenvatinibIBA
04/2022 - 01/2018
7Pharmaceutical PreparationsIBA
01/2022 - 12/2012
7Monoclonal AntibodiesIBA
06/2019 - 01/2003
6Tyrosine Kinase InhibitorsIBA
01/2022 - 12/2008
6Cyclin-Dependent Kinase 4IBA
01/2021 - 01/2015
5atezolizumabIBA
04/2022 - 01/2020
5Phenobarbital (Luminal)FDA Link
11/2020 - 11/2007
5Cyclin-Dependent Kinases (cdk Proteins)IBA
02/2019 - 01/2015
5human ERBB2 proteinIBA
11/2016 - 12/2008
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2022 - 01/2018
4regorafenibIBA
01/2019 - 01/2017
4Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2018 - 09/2012
4brivanibIBA
11/2014 - 04/2011
4Paclitaxel (Taxol)FDA LinkGeneric
11/2009 - 12/2008
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2022 - 09/2012
3NivolumabIBA
01/2022 - 01/2018
3Messenger RNA (mRNA)IBA
01/2022 - 12/2008
3AlbuminsIBA
09/2021 - 01/2021
3Fetal Proteins (Fetoprotein)IBA
06/2021 - 01/2019
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2014 - 03/2010
3Dasatinib (BMS 354825)FDA Link
05/2013 - 11/2007
3Epidermal Growth Factor (EGF)IBA
01/2013 - 12/2004
3Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2013 - 02/2009
2BilirubinIBA
09/2021 - 04/2021
2Estrogen Receptor Modulators (Antiestrogen)IBA
01/2020 - 03/2013
2Peptides (Polypeptides)IBA
01/2020 - 09/2012
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020 - 09/2012
2CreatinineIBA
10/2019 - 01/2019
2Cyclin DIBA
02/2019 - 01/2009
2Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
01/2018 - 05/2013
2infigratinibIBA
01/2018 - 05/2013
2GemcitabineFDA Link
01/2018 - 12/2014
2VimentinIBA
01/2018 - 11/2007
2Fulvestrant (Faslodex)FDA Link
02/2015 - 03/2013
2EverolimusFDA Link
02/2015 - 12/2013
25- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
06/2013 - 04/2013
2Biological ProductsIBA
06/2013 - 03/2011
2Tyrosine (L-Tyrosine)FDA Link
01/2013 - 08/2010
2dacomitinibIBA
01/2013 - 09/2012
2src-Family KinasesIBA
11/2011 - 08/2010
2AZD 6244IBA
07/2010 - 03/2010
2Progesterone Receptors (Progesterone Receptor)IBA
09/2009 - 08/2009
2Capecitabine (Xeloda)FDA Link
12/2008 - 01/2008
1roblitinibIBA
06/2022
1spartalizumabIBA
06/2022
1Combined Antibody TherapeuticsIBA
05/2021

Therapy/Procedure

58Therapeutics
01/2022 - 01/2003
10Liver Transplantation
01/2019 - 12/2010
8Drug Therapy (Chemotherapy)
01/2021 - 10/2007
2Immunotherapy
01/2022 - 01/2021
2Drug Tapering
12/2020 - 12/2019
2Transplantation
10/2020 - 10/2016
2Radiofrequency Ablation
01/2018 - 01/2017
1Duration of Therapy
06/2021